Allogene Therapeutics, Inc. (ALLO)
2.035
-0.06
(-2.63%)
USD |
NASDAQ |
Aug 24, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Gross Profit Margin (Quarterly) : 43.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.00% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | -16.06K% |
| December 31, 2023 | -16.46K% |
| Date | Value |
|---|---|
| September 30, 2023 | -16.14K% |
| June 30, 2023 | -16.46K% |
| March 31, 2023 | -11.59K% |
| December 31, 2022 | -6.94K% |
| September 30, 2022 | -8.91K% |
| June 30, 2022 | -5.54K% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | -8.22K% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | -5.24K% |
| March 31, 2021 | 89.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.62% |
| Return on Assets | -36.42% |
| Return on Invested Capital | -39.73% |
| Profit Margin (Quarterly) | -919.8% |
| Operating Margin (Quarterly) | -1.01K% |
| Return on Net Operating Assets | -146.6% |